<!DOCTYPE article
PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Archiving and Interchange DTD with MathML3 v1.3 20210610//EN" "JATS-archivearticle1-3-mathml3.dtd">
<article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" dtd-version="1.3" xml:lang="en" article-type="review-article"><?properties open_access?><processing-meta base-tagset="archiving" mathml-version="3.0" table-model="xhtml" tagset-family="jats"><restricted-by>pmc</restricted-by></processing-meta><front><journal-meta><journal-id journal-id-type="nlm-ta">Toxics</journal-id><journal-id journal-id-type="iso-abbrev">Toxics</journal-id><journal-id journal-id-type="publisher-id">toxics</journal-id><journal-title-group><journal-title>Toxics</journal-title></journal-title-group><issn pub-type="epub">2305-6304</issn><publisher><publisher-name>MDPI</publisher-name></publisher></journal-meta>
<article-meta><article-id pub-id-type="pmid">39997889</article-id><article-id pub-id-type="pmc">PMC11860408</article-id>
<article-id pub-id-type="doi">10.3390/toxics13020071</article-id><article-id pub-id-type="publisher-id">toxics-13-00071</article-id><article-categories><subj-group subj-group-type="heading"><subject>Review</subject></subj-group></article-categories><title-group><article-title>Uncovering the Potential Link Between Polychlorinated Biphenyls and Cardiovascular Diseases: A Comprehensive Analysis</article-title></title-group><contrib-group><contrib contrib-type="author"><name><surname>Liu</surname><given-names>Jingyu</given-names></name><xref rid="af1-toxics-13-00071" ref-type="aff">1</xref><xref rid="fn1-toxics-13-00071" ref-type="author-notes">&#x02020;</xref></contrib><contrib contrib-type="author"><name><surname>Shan</surname><given-names>Qiuli</given-names></name><xref rid="af1-toxics-13-00071" ref-type="aff">1</xref><xref rid="c1-toxics-13-00071" ref-type="corresp">*</xref><xref rid="fn1-toxics-13-00071" ref-type="author-notes">&#x02020;</xref></contrib><contrib contrib-type="author"><name><surname>Yang</surname><given-names>Yang</given-names></name><xref rid="af2-toxics-13-00071" ref-type="aff">2</xref></contrib><contrib contrib-type="author"><name><surname>He</surname><given-names>Wenxing</given-names></name><xref rid="af1-toxics-13-00071" ref-type="aff">1</xref><xref rid="c1-toxics-13-00071" ref-type="corresp">*</xref></contrib></contrib-group><contrib-group><contrib contrib-type="editor"><name><surname>Toft</surname><given-names>Gunnar</given-names></name><role>Academic Editor</role></contrib></contrib-group><aff id="af1-toxics-13-00071"><label>1</label>College of Biological Science and Technology, University of Jinan, Jinan 250022, China; <email>jy18739485166@163.com</email></aff><aff id="af2-toxics-13-00071"><label>2</label>College of Marine Life Science, Ocean University of China, Qingdao 266003, China; <email>21240613013@stu.ouc.edu.cn</email></aff><author-notes><corresp id="c1-toxics-13-00071"><label>*</label>Correspondence: <email>bio_shanql@ujn.edu.cn</email> (Q.S.); <email>chm_hewx@ujn.edu.cn</email> (W.H.)</corresp><fn id="fn1-toxics-13-00071"><label>&#x02020;</label><p>These authors contributed equally to this work.</p></fn></author-notes><pub-date pub-type="epub"><day>22</day><month>1</month><year>2025</year></pub-date><pub-date pub-type="collection"><month>2</month><year>2025</year></pub-date><volume>13</volume><issue>2</issue><elocation-id>71</elocation-id><history><date date-type="received"><day>19</day><month>12</month><year>2024</year></date><date date-type="rev-recd"><day>08</day><month>1</month><year>2025</year></date><date date-type="accepted"><day>13</day><month>1</month><year>2025</year></date></history><permissions><copyright-statement>&#x000a9; 2025 by the authors.</copyright-statement><copyright-year>2025</copyright-year><license><ali:license_ref xmlns:ali="http://www.niso.org/schemas/ali/1.0/" specific-use="textmining" content-type="ccbylicense">https://creativecommons.org/licenses/by/4.0/</ali:license_ref><license-p>Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (<ext-link ext-link-type="uri" xlink:href="https://creativecommons.org/licenses/by/4.0/">https://creativecommons.org/licenses/by/4.0/</ext-link>).</license-p></license></permissions><abstract><p>Background: A family of persistent organic pollutants, known as polychlorinated biphenyls (PCBs), are extensively found in the environment and may be harmful to the cardiovascular system. Systematic reviews and meta-analyses are required to thoroughly evaluate the association between PCB exposure and cardiovascular disease (CVDs), despite the fact that studies on the subject have produced inconsistent results. Objective: The purpose of this study was to investigate the relationship between PCBs exposure and cardiovascular disease risk in order to provide more conclusive data to promote public health actions. Methods: The studies that met the inclusion criteria were screened out using the databases PubMed, Web of Science, ScienceDirect, and Cochrane Library. The comprehensive effect size (OR) was calculated using the random-effects model; the study&#x02019;s heterogeneity was analyzed using I<sup>2</sup> statistics; the major reasons of heterogeneity were identified using subgroup analysis; and publication bias graphically was measured using the Egger&#x02019;s test. Results: A meta-analysis of 11 studies revealed that total PCBs (OR = 1.56, 95% CI: 1.20&#x02013;1.75), non-dioxin-like PCBs (NDL-PCBs) (OR = 1.33, 95% CI: 1.15&#x02013;1.53), and dioxin-like PCBs (DL-PCBs) (OR = 1.31, 95% CI: 1.10&#x02013;1.57) were all found to be positively associated with the risk of cardiovascular disease. Subgroup analysis revealed that study type, biomaterials, and literature quality were the most significant drivers of variation. Furthermore, certain PCB homologues, such as non-dioxin-like (NDL)-PCB153 and dioxin-like (DL)-PCB118, are highly related with cardiovascular disease. Conclusions: According to this meta-analysis, exposure to PCBs may increase the risk of cardiovascular disease. Notwithstanding major drawbacks, our results emphasize the significance of lowering exposure to PCBs and offering a solid theoretical basis for public health initiatives.</p></abstract><kwd-group><kwd>PCBs</kwd><kwd>CVDs</kwd><kwd>meta-analysis</kwd><kwd>systematic review</kwd><kwd>public health</kwd></kwd-group><funding-group><award-group><funding-source>The National Natural Science Foundation of China (NSFC)</funding-source><award-id>21507040</award-id><award-id>31872415</award-id></award-group><funding-statement>This research was funded by The National Natural Science Foundation of China (NSFC), grant numbers 21507040 and 31872415.</funding-statement></funding-group></article-meta></front><body><sec sec-type="intro" id="sec1-toxics-13-00071"><title>1. Introduction</title><p>Cardiovascular diseases (CVDs) are disorders that affect the heart and blood vessels, including coronary heart disease, myocardial infarction, stroke, and arteriosclerosis [<xref rid="B1-toxics-13-00071" ref-type="bibr">1</xref>]. These situations interrupt normal blood circulation and oxygen flow, which may cause organ damage [<xref rid="B2-toxics-13-00071" ref-type="bibr">2</xref>]. CVDs pose a significant global health threat and are among the main causes of death [<xref rid="B3-toxics-13-00071" ref-type="bibr">3</xref>]. They can lead to serious complications such as myocardial infarction and thrombosis, significantly impairing patients&#x02019; quality of life and posing potentially life-threatening risks [<xref rid="B4-toxics-13-00071" ref-type="bibr">4</xref>]. Obesity, hypertension, diabetes, high cholesterol and triglyceride levels, chronic psychological stress, genetic susceptibility, and bad lifestyle choices have all been identified as risk factors for CVDs [<xref rid="B5-toxics-13-00071" ref-type="bibr">5</xref>,<xref rid="B6-toxics-13-00071" ref-type="bibr">6</xref>]. Persistent organic pollutants (POPs) have received more attention lately. Studies show that POP exposure in the environment plays a major role in the development and progression of CVDs [<xref rid="B7-toxics-13-00071" ref-type="bibr">7</xref>].</p><p>POPs are natural or manmade organic contaminants that remain in environmental media such as air, water, soil, and living organisms for long periods, posing major hazards to the environment and human health [<xref rid="B8-toxics-13-00071" ref-type="bibr">8</xref>]. PCBs are a common class of POPs. According to studies, PCBs are persistent, bioaccumulative, semi-volatile, and highly poisonous [<xref rid="B9-toxics-13-00071" ref-type="bibr">9</xref>]. These compounds possess the potential to induce permanent damage to the neurological, endocrine, and reproductive systems. As lipophilic substances, they can disrupt intracellular lipid metabolism, thereby affecting metabolic and endocrine functions. There is a strong link between PCBs and chronic metabolic disorders, such as diabetes, obesity, CVDs, and other chronic diseases, according to recent epidemiological research [<xref rid="B10-toxics-13-00071" ref-type="bibr">10</xref>,<xref rid="B11-toxics-13-00071" ref-type="bibr">11</xref>]. PCBs have been linked to metabolic syndrome (MetS), which is linked to the type and homologue of PCBs, according to a meta-analysis [<xref rid="B12-toxics-13-00071" ref-type="bibr">12</xref>]. The findings of another meta-analysis indicate that PCBs, particularly DL-PCBs, constitute a significant risk factor for the development of hypertension [<xref rid="B13-toxics-13-00071" ref-type="bibr">13</xref>].</p><p>The number of articles and reports discussing the link between PCBs and CVDs has significantly increased in recent years, raising public awareness of PCBs. Individual studies produced inconsistent or contradictory results, and there has been some research on the association between PCBs and CVDs, but it has not been systematically integrated as of late. A 2016 cohort study of men who were Swedish citizens in 1997 discovered a link between dietary PCB exposure and an increased risk of myocardial infarction [<xref rid="B14-toxics-13-00071" ref-type="bibr">14</xref>]. On the other hand, a cross-sectional examination in 2020 revealed a common association between coronary artery calcification and PCB exposure not seen in the diet [<xref rid="B15-toxics-13-00071" ref-type="bibr">15</xref>]. A 2021 study linked six serum PCB homologues to CVD prevalence [<xref rid="B16-toxics-13-00071" ref-type="bibr">16</xref>]. In contrast, Laura Deen et al. found no such association [<xref rid="B17-toxics-13-00071" ref-type="bibr">17</xref>]. Therefore, more research is required to validate the link between PCBs and CVDs.</p><p>The objectives we set in doing this meta-analysis were to better understand the variations in PCBs levels across individuals with and without CVDs and to assess the correlation between PCBs and CVDs. Additionally, we performed a subgroup analysis of research design, PCB type, and article quality, three possible impacting factors.</p></sec><sec id="sec2-toxics-13-00071"><title>2. Materials and Methods</title><sec id="sec2dot1-toxics-13-00071"><title>2.1. Methods</title><p>This study was conducted in accordance with the PRISMA 2020 (Preferred Reporting Items for Systematic Reviews and Meta-Analyses) [<xref rid="B18-toxics-13-00071" ref-type="bibr">18</xref>] statement and the MOOSE (Meta-analyses of Observational Studies in Epidemiology) guidelines [<xref rid="B19-toxics-13-00071" ref-type="bibr">19</xref>]. This study has been registered as PROSPERO, Registration number CRD42024563475. The following is the Population, Exposure, Comparator, and Outcome (PECO) [<xref rid="B20-toxics-13-00071" ref-type="bibr">20</xref>] for this topic: Population (P): General population, including those exposed to PCBs. Exposure (E): Exposure to or increased exposure to PCBs as indicated by the results of human blood, serum, or adipose tissue tests. Comparator (C): Unexposed or less exposed to PCBs (if applicable) or lowest PCB exposure group. Outcome (O): Occurrence of CVDs.</p></sec><sec id="sec2dot2-toxics-13-00071"><title>2.2. Exposure and Outcome Measures</title><p>Assessments were conducted individually for PCBs, dioxin-like (DL) PCBs, non-dioxin-like (NDL) PCBs, and selected individual congeners. The primary outcome was incidence or prevalence of CVDs.</p></sec><sec id="sec2dot3-toxics-13-00071"><title>2.3. Literature Sources and Search Methodologies</title><p>Our research team looked through PubMed, ScienceDirect, Web of Science, and the Cochrane Library for pertinent literature. Database retrieval period began on 1 March 2024. Due to variations in search methods across different websites, the keywords used for searches may differ. Please refer to <xref rid="app1-toxics-13-00071" ref-type="app">Supplementary Materials</xref> for specific search strategies.</p></sec><sec id="sec2dot4-toxics-13-00071"><title>2.4. Criteria for Study Selection</title><p>Studies that fulfilled the following criteria were considered epidemiological: (1) any demographic or subject group; (2) case-control, cross-sectional, and queuing study designs (the literature that is included needs to address the connection between cardiovascular illnesses and homologues of polychlorinated biphenyls); (3) biological samples (blood, serum, or adipose tissue) for the purpose of measuring PCBs directly or indirectly through consumption of PCB-estimating foods; (4) the incidence or prevalence of cardiovascular disease, together with the related 95% confidence intervals (CI) for the hazard ratio (HR), relative risk ratio (RR), and odds ratio (OR); (5) English should be the language used for the included books; (6) original research should be the genre of the incorporated literature.</p></sec><sec id="sec2dot5-toxics-13-00071"><title>2.5. Criteria for Study Exclusion</title><p>Our exclusion criteria were: (1) Studies that are not research-focused on PCBs and CVDs; (2) literature encompassing both animal and in vitro experiments; (3) the language of literature is not English; (4) topics for literature include reviews, analyses, abstracts, and so on; (5) studies lacking valid data in their findings.</p></sec><sec id="sec2dot6-toxics-13-00071"><title>2.6. Quality Evaluation</title><p>For the cohort and case-control studies included in the literature, the Newcastle&#x02013;Ottawa Quality-Assessment Scale (NOS) was used for evaluation [<xref rid="B21-toxics-13-00071" ref-type="bibr">21</xref>]; for cross-sectional studies, a modified NOS scale [<xref rid="B22-toxics-13-00071" ref-type="bibr">22</xref>] was applied.</p></sec><sec id="sec2dot7-toxics-13-00071"><title>2.7. Data Extraction</title><p>We will extract the following information from all included studies: authors, publication year, design of the study, location, study population, study period, sample size, gender ratio, age distribution, biological substances, types of PCBs, methods of PCBs measurement, outcomes, and main findings.</p></sec><sec id="sec2dot8-toxics-13-00071"><title>2.8. Result Analysis</title><p>The effect sizes and confidence intervals between PCBs and CVDs will be calculated using the raw data from the literature. The relationship between PCBs and CVDs will be investigated through the synthesis of effect sizes. The heterogeneity of the combined effect was examined using the Q test. A significant level of heterogeneity is indicated by an effect size of the Q test (I<sup>2</sup>) larger than 50%, at which point the random-effects model ought to be applied. A fixed-effect model should be used when the heterogeneity is deemed low [<xref rid="B23-toxics-13-00071" ref-type="bibr">23</xref>] and the I<sup>2</sup> value is less than 50%.</p><p>Subgroup analysis will be used to investigate the sources of heterogeneity when they are high. Utilizing the funnel plot and Egger test method, the publication bias of the included literature was quantified. To determine how each study affected the total effect size, we conducted sensitivity analyses. After removing one study per round, we ran the meta-analysis. Using stratified analyses, potential causes of heterogeneity related to the quality of the literature, research design, or PCB type were evaluated. The amount of possible confounding (unmeasured, unknown, OR residual) was estimated using the total PCBs measured with OR as the effect, and the e values were provided.</p><p>A smaller e value indicates that less unmeasurable confounding is needed to explain the impact estimate, whereas a greater e value indicates the necessity for substantial unmeasurable confounding. Stata MP14 (521.14.0.366) and Review Manager 5.3 (5.3.5.0) were used for the statistical analysis.</p></sec></sec><sec id="sec3-toxics-13-00071"><title>3. Result</title><sec id="sec3dot1-toxics-13-00071"><title>3.1. Screening Process</title><p>The Cochrane Library, Web of Science, ScienceDirect, and PubMed were the sources of 749 papers that we retrieved. Following a literature search, two researchers (Jingyu Liu and Yang Yang) separately chose the literature. For any objections, the third reviewer (Qiuli Shan) provides additional feedback.</p><p>Six hundred forty articles were initially removed based on our inclusion and exclusion criteria after reviewing the titles and abstracts. Following the completion of the literature extraction, the articles that did not meet the requirements and those for which the complete text could not be retrieved were rejected individually by two researchers. After reviewing the full text of the remaining publications using the inclusion and exclusion criteria, a total of 11 papers were included in this analysis, with no articles eliminated due to a lack of complete text (<xref rid="toxics-13-00071-f001" ref-type="fig">Figure 1</xref>).</p></sec><sec id="sec3dot2-toxics-13-00071"><title>3.2. Research Characteristics</title><p>The characteristics of the included studies are presented in <xref rid="toxics-13-00071-t001" ref-type="table">Table 1</xref>. This systematic review comprised seven cohort studies, three case-control studies, and one cross-sectional research. Five investigations were undertaken in Sweden, two in Spain, and one each in Denmark, Italy, China, and the Republic of Korea. Considering five studies including more than 300 participants and six studies involving more than 1300 participants, the study population was generally big. Eight of the studies included high-exposure subgroups, and three examined the overall population. The majority of research calculates exposure by adding up all of the PCB homologues. Nine studies measured PCB concentrations in serum or plasma, one study measured PCB concentrations in adipose tissue, and one study tested PCB concentrations in lipids. These findings provide insight into the methodologies used to estimate PCB exposure. Nine of the nine studies that assessed PCBs in blood or serum did so as a ratio of total lipids to PCB serum levels (standardized). Almost all studies controlled for age (<italic toggle="yes">n</italic> = 10), smoking habits (<italic toggle="yes">n</italic> = 10), education (<italic toggle="yes">n</italic> = 9), and body mass index (<italic toggle="yes">n</italic> = 9), and most also adjusted for alcohol consumption (<italic toggle="yes">n</italic> = 8), physical activity (<italic toggle="yes">n</italic> = 7), sex (<italic toggle="yes">n</italic> = 7), and sex (<italic toggle="yes">n</italic> = 7). Some studies also adjusted for triglycerides or cholesterol (<italic toggle="yes">n</italic> = 8), family history of genetic disease (<italic toggle="yes">n</italic> = 5), and diabetes (<italic toggle="yes">n</italic> = 4) (<xref rid="app1-toxics-13-00071" ref-type="app">Supplemental Materials Table S1</xref>).</p></sec><sec id="sec3dot3-toxics-13-00071"><title>3.3. Comprehensive Analysis</title><p>We carefully read the 11 included articles [<xref rid="B14-toxics-13-00071" ref-type="bibr">14</xref>,<xref rid="B15-toxics-13-00071" ref-type="bibr">15</xref>,<xref rid="B16-toxics-13-00071" ref-type="bibr">16</xref>,<xref rid="B17-toxics-13-00071" ref-type="bibr">17</xref>,<xref rid="B24-toxics-13-00071" ref-type="bibr">24</xref>,<xref rid="B25-toxics-13-00071" ref-type="bibr">25</xref>,<xref rid="B26-toxics-13-00071" ref-type="bibr">26</xref>,<xref rid="B27-toxics-13-00071" ref-type="bibr">27</xref>,<xref rid="B28-toxics-13-00071" ref-type="bibr">28</xref>,<xref rid="B29-toxics-13-00071" ref-type="bibr">29</xref>,<xref rid="B30-toxics-13-00071" ref-type="bibr">30</xref>], extracted the effect indicators of PCBs and CVDs, combined them for meta-analysis, and the results were represented by forest maps, as shown in <xref rid="toxics-13-00071-f002" ref-type="fig">Figure 2</xref>. Through data extraction and analysis, a summary of PCBs and CVDs was produced from the article. When the data were merged, they showed a strong correlation between PCB exposure and the risk of cardiovascular disease (OR = 1.56, 95% CI: 1.28, 1.90, <italic toggle="yes">p</italic> &#x0003c; 0.001). The next section will address the reasons for the significant heterogeneity in this analysis (I<sup>2</sup> = 81.3%), as indicated by the meta-analysis.</p><p>First, we tested for publication bias using the collected literature. The findings were plotted as a funnel plot in <xref rid="toxics-13-00071-f003" ref-type="fig">Figure 3</xref>, suggesting that the meta-analysis may have some publication bias. To investigate the possibility of publication bias, we used the Egger test on the compiled literature. The test results are displayed in <xref rid="app1-toxics-13-00071" ref-type="app">Supplemental Materials Table S2</xref>. There is publication bias in the included literature, as indicated by the <italic toggle="yes">p</italic>-value of 0.001. Subsequently, sensitivity analysis was performed on the included studies, and the results are displayed in <xref rid="toxics-13-00071-f004" ref-type="fig">Figure 4</xref>, which demonstrates the robustness of the findings. Consequently, in order to investigate the reasons for heterogeneity, we performed a subgroup analysis.</p><sec id="sec3dot3dot1-toxics-13-00071"><title>3.3.1. Subgroup Analysis of Literature Quality</title><p>The case-control, cohort, and cross-sectional studies were assessed separately, and the quality of the 11 included publications was assessed using the NOS scoring technique (<xref rid="toxics-13-00071-f005" ref-type="fig">Figure 5</xref>). It can be seen from the figure that there are three kinds of literature of high quality [<xref rid="B14-toxics-13-00071" ref-type="bibr">14</xref>,<xref rid="B15-toxics-13-00071" ref-type="bibr">15</xref>,<xref rid="B17-toxics-13-00071" ref-type="bibr">17</xref>] and eight kinds of literature of medium quality [<xref rid="B16-toxics-13-00071" ref-type="bibr">16</xref>,<xref rid="B24-toxics-13-00071" ref-type="bibr">24</xref>,<xref rid="B25-toxics-13-00071" ref-type="bibr">25</xref>,<xref rid="B26-toxics-13-00071" ref-type="bibr">26</xref>,<xref rid="B27-toxics-13-00071" ref-type="bibr">27</xref>,<xref rid="B28-toxics-13-00071" ref-type="bibr">28</xref>,<xref rid="B29-toxics-13-00071" ref-type="bibr">29</xref>,<xref rid="B30-toxics-13-00071" ref-type="bibr">30</xref>]. The analysis results are shown in <xref rid="toxics-13-00071-f006" ref-type="fig">Figure 6</xref>, including the group of high quality (OR = 1.38, 95% CI: 0.95, 1.99, <italic toggle="yes">p</italic> &#x0003c; 0.001, I<sup>2</sup> = 90.1%) and the medium-quality group (OR = 1.61, 95% CI: 1.35, 1.92, <italic toggle="yes">p</italic> = 0.107, I<sup>2</sup> = 40.8%). The results demonstrate that, whereas the medium-quality group has minimal variability, the high-quality group has significant heterogeneity. According to this analysis, one of the factors contributing to the high consistency of comprehensive results is the high caliber of the literature.</p></sec><sec id="sec3dot3dot2-toxics-13-00071"><title>3.3.2. Subgroup Analysis Based on the Kind of Biomaterials Was Conducted</title><p>The types of biomaterials included in the literature were subgroups analyzed by serum and plasma. The results of the subgroup analysis are shown in <xref rid="toxics-13-00071-f007" ref-type="fig">Figure 7</xref>. The results in the serum group were as follows: (OR = 1.64, 95% CI: 1.43, 1.88, <italic toggle="yes">p</italic> = 0.592, I<sup>2</sup> = 0%). The results of plasma group were as follows: (OR = 1.51, 95% CI: 0.91, 2.52, <italic toggle="yes">p</italic> &#x0003c; 0.001, I<sup>2</sup> = 86.4%). According to the data, the plasma group had a significant degree of heterogeneity compared to the serum group&#x02019;s low level. It is possible to argue that one of the causes of the significant heterogeneity of the overall results was the type of biomaterial called plasma.</p></sec><sec id="sec3dot3dot3-toxics-13-00071"><title>3.3.3. Subgroup Analysis Took out Based on the Type of Study</title><p>Subgroup analysis was conducted in accordance with the study&#x02019;s design. <xref rid="toxics-13-00071-f008" ref-type="fig">Figure 8</xref> displays the findings of the analysis. The following are the cohort study&#x02019;s findings: (OR = 1.59, 95% CI: 1.22, 2.09, <italic toggle="yes">p</italic> &#x0003c; 0.001, I<sup>2</sup> = 86.1%); The case-control analysis yielded the following results: (OR = 1.60, 95% CI: 1.28, 2.02, <italic toggle="yes">p</italic> = 0.933, I<sup>2</sup> = 0%). As can be observed, the cohort study group has a high level of heterogeneity compared to the case-control study group, which has a low level. The significant degree of variation in the comprehensive results is thought to be caused, in part, by the type of study that was included in the literature.</p></sec><sec id="sec3dot3dot4-toxics-13-00071"><title>3.3.4. Subpopulation Analysis Based on PCB Type Was Conducted</title><p>According to the types of PCBs, the literature was divided into the DL-PCB group [<xref rid="B16-toxics-13-00071" ref-type="bibr">16</xref>,<xref rid="B24-toxics-13-00071" ref-type="bibr">24</xref>,<xref rid="B26-toxics-13-00071" ref-type="bibr">26</xref>,<xref rid="B29-toxics-13-00071" ref-type="bibr">29</xref>] and the NDL-PCB group [<xref rid="B24-toxics-13-00071" ref-type="bibr">24</xref>,<xref rid="B26-toxics-13-00071" ref-type="bibr">26</xref>,<xref rid="B28-toxics-13-00071" ref-type="bibr">28</xref>,<xref rid="B29-toxics-13-00071" ref-type="bibr">29</xref>]. <xref rid="toxics-13-00071-f009" ref-type="fig">Figure 9</xref> displays the outcomes of the subgroup analysis. The following were the NDL-PCB group&#x02019;s findings: DL-PCB group results were as follows (OR = 1.31, 95% CI: 1.10, 1.57, <italic toggle="yes">p</italic> = 0.199, I<sup>2</sup> = 31.6%; OR = 1.33, 95% CI: 1.15, 1.53, <italic toggle="yes">p</italic> = 0.347, I<sup>2</sup> = 9.3%). The substantial heterogeneity of the comprehensive results cannot be attributed to the type of PCBs, as the heterogeneity of the DL-PCB group and the NDL-PCB group is both low and not significant. The findings suggested that there was a higher risk of cardiovascular illness associated with both DL-PCBs and NDL-PCBs.</p><p>In addition, we conducted a subpopulation analysis of different homologues of PCB types. As for the effects of different PCBs on cardiovascular diseases, four articles [<xref rid="B16-toxics-13-00071" ref-type="bibr">16</xref>,<xref rid="B24-toxics-13-00071" ref-type="bibr">24</xref>,<xref rid="B27-toxics-13-00071" ref-type="bibr">27</xref>,<xref rid="B29-toxics-13-00071" ref-type="bibr">29</xref>] reported PCB153, PCB138, and PCB180 for NDL-PCBs. <xref rid="app1-toxics-13-00071" ref-type="app">Supplementary Figure S1</xref> displays the findings for PCB153 (OR = 1.32, 95% CI: 1.19, 1.45, <italic toggle="yes">p</italic> = 0.411, I<sup>2</sup> = 0%); PCB138 (OR = 1.19, 95% CI: 0.93, 1.54, <italic toggle="yes">p</italic> = 0.021, I<sup>2</sup> = 69.2%); and PCB180 (OR = 1.09, 95% CI: 0.99, 1.19, <italic toggle="yes">p</italic> = 0.705, I<sup>2</sup> = 0%). A strong conclusion was reached by using the fixed-effect model, which demonstrated a positive correlation between PCB153 and the incidence of cardiovascular illnesses without any heterogeneity.</p><p>This was followed by DL-PCBs, with three articles [<xref rid="B24-toxics-13-00071" ref-type="bibr">24</xref>,<xref rid="B26-toxics-13-00071" ref-type="bibr">26</xref>,<xref rid="B29-toxics-13-00071" ref-type="bibr">29</xref>] reporting PCB118 and PCB156. <xref rid="app1-toxics-13-00071" ref-type="app">Supplemental Materials Figure S2</xref> displays the findings for PCB118 (OR = 1.26, 95% CI: 1.04, 1.52, <italic toggle="yes">p</italic> = 0.408, I<sup>2</sup> = 1.2%) and PCB156 (OR = 1.18, 95% CI: 0.83, 1.67, <italic toggle="yes">p</italic> = 0.060, I<sup>2</sup> = 52.8%). PCB118 was shown to have a significant increase in the risk of cardiovascular disease among them. The conclusion was supported by the low level of heterogeneity.</p></sec></sec></sec><sec sec-type="discussion" id="sec4-toxics-13-00071"><title>4. Discussion</title><p>We conducted a meta-analysis and systematic review to examine the link between cardiovascular disease and PCB exposure. We draw the conclusion that, due to its great heterogeneity, PCB exposure is a risk factor for cardiovascular disease based on a selection of 11 epidemiological studies conducted up until March 2024 among six nations. As a result, we performed subgroup analysis based on the biological material, research type, article quality, and PCB type. We discovered that these factors could be the cause of the article&#x02019;s high heterogeneity.</p><p>The results of the subgroup analysis of PCB types for NDL-PCBs (OR = 1.33, 95% CI: 1.15, 1.53) and DL-PCBs (OR = 1.31, 95% CI: 1.10, 1.57) all indicated a low degree of heterogeneity in the positive association between PCBs and the risk of cardiovascular disease. NDL-PCB-153 (OR = 1.32, 95% CI: 1.19, 1.45) and DL-PCB-118 (OR = 1.26, 95% CI: 1.04, 1.52) were found to be risk variables for cardiovascular disease in homologous subgroup analysis. The E value of the PCB effect on cardiovascular disease was calculated in this study, and the result was 2.259, indicating a high degree of confidence and relative robustness. As a result, we think that our analysis&#x02019;s findings are more precise and compelling.</p><p>The molecular pathways that could link PCBs to cardiovascular disease have been examined in earlier research. PCBs are well-known endocrine disruptors that mimic or obstruct the body&#x02019;s hormonal functions, particularly those of the thyroid and sex hormones [<xref rid="B31-toxics-13-00071" ref-type="bibr">31</xref>]. The changes in the metabolic rate induced by this disruption may affect the functioning of the cardiovascular system. For example, an imbalance in thyroid hormones can lead to abnormal blood pressure, altered cholesterol levels, and irregular heart rhythms, each of which is a known risk factor for cardiovascular disease [<xref rid="B32-toxics-13-00071" ref-type="bibr">32</xref>]. Research has indicated that estrogen functions as a cardiac protective agent, regulating cardiovascular health and lowering blood pressure, vasoconstriction, vascular resistance, and heart hypertrophy [<xref rid="B33-toxics-13-00071" ref-type="bibr">33</xref>]. These effects provide protection against cardiovascular disease, and an excess of estrogen may actually exacerbate the condition [<xref rid="B33-toxics-13-00071" ref-type="bibr">33</xref>].</p><p>Chronic inflammation is closely linked to the onset of cardiovascular disease, particularly when atherosclerosis is forming. The growth and accumulation of plaque may be aided by the activation and deposition of inflammatory cells in the blood vessel wall [<xref rid="B34-toxics-13-00071" ref-type="bibr">34</xref>]. The accumulation and activation of inflammatory cells in the vascular wall can promote the formation and progression of plaques. Dioxin-like PCBs (DL-PCBs) can initiate intracellular signaling by binding to the aryl hydrocarbon receptor (AHR), thereby activating inflammatory pathways in the body. For example, PCB126 induces inflammation by increasing the production of the inflammatory cytokine tumor necrosis factor-&#x003b1; (TNF-&#x003b1;) [<xref rid="B35-toxics-13-00071" ref-type="bibr">35</xref>]. Studies have demonstrated that non-dioxin-like PCBs (NDL-PCBs) can stimulate the production of reactive oxygen species (ROS), leading to oxidative stress [<xref rid="B36-toxics-13-00071" ref-type="bibr">36</xref>]. The oxidative stress induced by PCB118 may contribute to endothelial dysfunction, increased lipid peroxidation, and the degradation of nitric oxide in the endothelium, thereby impairing vascular relaxation and exacerbating hypertension and arteriosclerosis [<xref rid="B36-toxics-13-00071" ref-type="bibr">36</xref>]. Furthermore, exposure to PCB153, a dioxin-like PCB (DL-PCB), may lead to the downregulation of lipoprotein lipase (LPL) activity, thereby affecting the hydrolysis and absorption of lipids. This, in turn, results in elevated levels of low-density lipoprotein (LDL) in the blood, thereby increasing the risk of cardiovascular disease [<xref rid="B37-toxics-13-00071" ref-type="bibr">37</xref>].</p><p>The shortcomings of this meta-analysis are numerous. With only 11 studies included, it has a small sample size and low representativeness, which increases the risk of bias. Significant variability between the studies was also discovered in the analysis, with differing levels of research quality, measurement errors in exposure levels, and inadequate management of confounding variables. Generally speaking, a significant cause of heterogeneity is the variable quality of the included research. According to this research, high-quality studies could contain selection biases that impede their findings from accurately representing the target population&#x02019;s real circumstances. Moreover, variations in sample size, follow-up duration, and data-processing techniques between the studies could impact the consistency and dependability of the findings. A dearth of high-caliber studies may also affect the results. The main focus of this investigation was on biological materials containing serum and plasma. Due to their high lipophilicity, PCBs usually attach to blood proteins. The changes in serum and plasma composition, especially the presence of coagulation factors, may have an impact on PCB binding status [<xref rid="B38-toxics-13-00071" ref-type="bibr">38</xref>,<xref rid="B39-toxics-13-00071" ref-type="bibr">39</xref>].</p><p>The action of coagulation factors may cause changes in plasma during storage, which could have an impact on PCB stability and measurement outcomes. Serum, on the other hand, remains reasonably stable following separation, which could lead to more accurate measurement results [<xref rid="B40-toxics-13-00071" ref-type="bibr">40</xref>]. Cross-sectional, case-control, and cohort studies are the study types that are considered; an additional source of heterogeneity is the variations in these study designs. Subgroup analysis on case-control and cohort studies is the main focus of this research. Recall and selection bias are common problems in case-control research. On the other hand, longitudinal cohort studies, which frequently necessitate lengthy follow-up periods and substantial resources, are better able to evaluate the temporal association between exposure and disease. Moreover, a number of confounding variables, including nutrition, physical activity, education level, socioeconomic position, smoking, drinking alcohol, and exposure to other environmental contaminants, can affect the association between PCB exposure and cardiovascular disease. Variations in the degree to which these characteristics are adjusted in different studies may lead to biased findings. Furthermore, while examining the connection between PCBs and cardiovascular illness, it is important to consider the level of exposure, the length of exposure, and the relevant lifetime periods of sensitivity.</p></sec><sec sec-type="conclusions" id="sec5-toxics-13-00071"><title>5. Conclusions</title><p>The connection between PCB exposure and the risk of CVDs was thoroughly assessed in this meta-analysis, which found that exposure to PCBs considerably raises the risk of CVDs. This discovery offers crucial scientific support for our comprehension of how environmental contaminants affect human health. Despite certain methodological limitations, the study&#x02019;s findings generally show a favorable association between exposure to PCBs and cardiovascular diseases. The current findings provide preliminary evidence for a potential association between PCBs and cardiovascular disease. However, this field still requires more detailed studies to further elucidate the underlying mechanisms and the diversity of effects. In conclusion, this study emphasizes the significance of lowering exposure to PCBs and offers a solid scientific foundation for therapeutic and public health actions. It highlights the need for individuals and society to take measures to reduce PCB exposure in order to lower the risk of CVDs.</p></sec></body><back><fn-group><fn><p><bold>Disclaimer/Publisher&#x02019;s Note:</bold> The statements, opinions and data contained in all publications are solely those of the individual author(s) and contributor(s) and not of MDPI and/or the editor(s). MDPI and/or the editor(s) disclaim responsibility for any injury to people or property resulting from any ideas, methods, instructions or products referred to in the content.</p></fn></fn-group><app-group><app id="app1-toxics-13-00071"><title>Supplementary Materials</title><p>The following supporting information can be downloaded at: <uri xlink:href="https://www.mdpi.com/article/10.3390/toxics13020071/s1">https://www.mdpi.com/article/10.3390/toxics13020071/s1</uri>, Search term; Table S1: Control for confounding; Table S2: Egger&#x02019;s test of total PCBs and CVDs; Figure S1: Forest map with NDL-PCB homolog as a grouping; Figure S2: Forest map featuring DL-PCB homolog as a distinct subgroup.</p><supplementary-material id="toxics-13-00071-s001" position="float" content-type="local-data"><media xlink:href="toxics-13-00071-s001.zip"/></supplementary-material></app></app-group><notes><title>Author Contributions</title><p>Conceptualization, J.L., methodology, data curation, software, formal analysis, writing&#x02014;original draft; Q.S., data curation, writing&#x02014;original draft, writing&#x02014;review and editing; Y.Y., methodology, software; W.H., funding acquisition, resources, supervision, writing&#x02014;review and editing. This work is original research that has not been published previously and is not under publication consideration elsewhere. All authors have read and agreed to the published version of the manuscript.</p></notes><notes><title>Institutional Review Board Statement</title><p>Not applicable.</p></notes><notes><title>Informed Consent Statement</title><p>Not applicable.</p></notes><notes notes-type="data-availability"><title>Data Availability Statement</title><p>The data that support the findings of this study are available from the corresponding author upon reasonable request.</p></notes><notes notes-type="COI-statement"><title>Conflicts of Interest</title><p>There is no potential conflict of interest to disclose.</p></notes><ref-list><title>References</title><ref id="B1-toxics-13-00071"><label>1.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Piepoli</surname><given-names>M.F.</given-names></name>
</person-group><article-title>2016 European Guidelines on cardiovascular disease prevention in clinical practice: The Sixth Joint Task Force of the European Society of Cardiology and Other Societies on Cardiovascular Disease Prevention in Clinical Practice (constituted by representatives of 10 societies and by invited experts)</article-title><source>Int. J. Behav. Med.</source><year>2017</year><volume>24</volume><fpage>321</fpage><lpage>419</lpage><pub-id pub-id-type="doi">10.1007/s12529-016-9583-6</pub-id><pub-id pub-id-type="pmid">28290077</pub-id>
</element-citation></ref><ref id="B2-toxics-13-00071"><label>2.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Teshale</surname><given-names>A.B.</given-names></name>
<name><surname>Htun</surname><given-names>H.L.</given-names></name>
<name><surname>Hu</surname><given-names>J.</given-names></name>
<name><surname>Dalli</surname><given-names>L.L.</given-names></name>
<name><surname>Lim</surname><given-names>M.H.</given-names></name>
<name><surname>Neves</surname><given-names>B.B.</given-names></name>
<name><surname>Baker</surname><given-names>J.</given-names></name>
<name><surname>Phyo</surname><given-names>A.Z.Z.</given-names></name>
<name><surname>Reid</surname><given-names>C.M.</given-names></name>
<name><surname>Ryan</surname><given-names>J.</given-names></name>
<etal/>
</person-group><article-title>The relationship between social isolation, social support, and loneliness with cardiovascular disease and shared risk factors: A narrative review</article-title><source>Arch. Gerontol. Geriatr.</source><year>2023</year><volume>111</volume><fpage>105008</fpage><pub-id pub-id-type="doi">10.1016/j.archger.2023.105008</pub-id><pub-id pub-id-type="pmid">37003026</pub-id>
</element-citation></ref><ref id="B3-toxics-13-00071"><label>3.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Fang</surname><given-names>N.</given-names></name>
<name><surname>Jiang</surname><given-names>M.</given-names></name>
<name><surname>Fan</surname><given-names>Y.</given-names></name>
</person-group><article-title>Ideal cardiovascular health metrics and risk of cardiovascular disease or mortality: A meta-analysis</article-title><source>Int. J. Cardiol.</source><year>2016</year><volume>214</volume><fpage>280</fpage><lpage>284</lpage><pub-id pub-id-type="doi">10.1016/j.ijcard.2016.03.210</pub-id><pub-id pub-id-type="pmid">27085116</pub-id>
</element-citation></ref><ref id="B4-toxics-13-00071"><label>4.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Machaalani</surname><given-names>M.</given-names></name>
<name><surname>Fakhry</surname><given-names>B.</given-names></name>
<name><surname>Zwaihed</surname><given-names>M.</given-names></name>
<name><surname>Mendelek</surname><given-names>K.</given-names></name>
<name><surname>Mahmoud</surname><given-names>N.</given-names></name>
<name><surname>Hammoud</surname><given-names>T.</given-names></name>
<name><surname>Chahine</surname><given-names>M.N.</given-names></name>
</person-group><article-title>Knowledge, Attitude, and Practice Toward Cardiovascular Diseases in the Lebanese Population</article-title><source>Glob. Heart</source><year>2022</year><volume>17</volume><fpage>47</fpage><pub-id pub-id-type="doi">10.5334/gh.1138</pub-id><pub-id pub-id-type="pmid">36051313</pub-id>
</element-citation></ref><ref id="B5-toxics-13-00071"><label>5.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Arrebola</surname><given-names>J.P.</given-names></name>
<name><surname>Fern&#x000e1;ndez</surname><given-names>M.F.</given-names></name>
<name><surname>Martin-Olmedo</surname><given-names>P.</given-names></name>
<name><surname>Bonde</surname><given-names>J.P.</given-names></name>
<name><surname>Mart&#x000ed;n-Rodriguez</surname><given-names>J.L.</given-names></name>
<name><surname>Exp&#x000f3;sito</surname><given-names>J.</given-names></name>
<name><surname>Rubio-Dom&#x000ed;nguez</surname><given-names>A.</given-names></name>
<name><surname>Olea</surname><given-names>N.</given-names></name>
</person-group><article-title>Historical exposure to persistent organic pollutants and risk of incident hypertension</article-title><source>Environ. Res.</source><year>2015</year><volume>138</volume><fpage>217</fpage><lpage>223</lpage><pub-id pub-id-type="doi">10.1016/j.envres.2015.02.018</pub-id><pub-id pub-id-type="pmid">25725302</pub-id>
</element-citation></ref><ref id="B6-toxics-13-00071"><label>6.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Ge</surname><given-names>L.</given-names></name>
<name><surname>Guyatt</surname><given-names>G.</given-names></name>
<name><surname>Tian</surname><given-names>J.</given-names></name>
<name><surname>Pan</surname><given-names>B.</given-names></name>
<name><surname>Chang</surname><given-names>Y.</given-names></name>
<name><surname>Chen</surname><given-names>Y.</given-names></name>
<name><surname>Li</surname><given-names>H.</given-names></name>
<name><surname>Zhang</surname><given-names>J.</given-names></name>
<name><surname>Li</surname><given-names>Y.</given-names></name>
<name><surname>Ling</surname><given-names>J.</given-names></name>
<etal/>
</person-group><article-title>Insomnia and risk of mortality from all-cause, cardiovascular disease, and cancer: Systematic review and meta-analysis of prospective cohort studies</article-title><source>Sleep Med. Rev.</source><year>2019</year><volume>48</volume><fpage>101215</fpage><pub-id pub-id-type="doi">10.1016/j.smrv.2019.101215</pub-id><pub-id pub-id-type="pmid">31630016</pub-id>
</element-citation></ref><ref id="B7-toxics-13-00071"><label>7.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Peng</surname><given-names>F.-J.</given-names></name>
<name><surname>Lin</surname><given-names>C.-A.</given-names></name>
<name><surname>Wada</surname><given-names>R.</given-names></name>
<name><surname>Bodinier</surname><given-names>B.</given-names></name>
<name><surname>Iglesias-Gonz&#x000e1;lez</surname><given-names>A.</given-names></name>
<name><surname>Palazzi</surname><given-names>P.</given-names></name>
<name><surname>Streel</surname><given-names>S.</given-names></name>
<name><surname>Guillaume</surname><given-names>M.</given-names></name>
<name><surname>Vuckovic</surname><given-names>D.</given-names></name>
<name><surname>Chadeau-Hyam</surname><given-names>M.</given-names></name>
<etal/>
</person-group><article-title>Association of hair polychlorinated biphenyls and multiclass pesticides with obesity, diabetes, hypertension and dyslipidemia in NESCAV study</article-title><source>J. Hazard. Mater.</source><year>2024</year><volume>461</volume><fpage>132637</fpage><pub-id pub-id-type="doi">10.1016/j.jhazmat.2023.132637</pub-id><pub-id pub-id-type="pmid">37788552</pub-id>
</element-citation></ref><ref id="B8-toxics-13-00071"><label>8.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Hoyeck</surname><given-names>M.P.</given-names></name>
<name><surname>Matteo</surname><given-names>G.</given-names></name>
<name><surname>MacFarlane</surname><given-names>E.M.</given-names></name>
<name><surname>Perera</surname><given-names>I.</given-names></name>
<name><surname>Bruin</surname><given-names>J.E.</given-names></name>
</person-group><article-title>Persistent organic pollutants and &#x003b2;-cell toxicity: A comprehensive review</article-title><source>Am. J. Physiol.-Endocrinol. Metab.</source><year>2022</year><volume>322</volume><fpage>E383</fpage><lpage>E413</lpage><pub-id pub-id-type="doi">10.1152/ajpendo.00358.2021</pub-id><pub-id pub-id-type="pmid">35156417</pub-id>
</element-citation></ref><ref id="B9-toxics-13-00071"><label>9.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Alharbi</surname><given-names>O.M.</given-names></name>
<name><surname>Basheer</surname><given-names>A.A.</given-names></name>
<name><surname>Khattab</surname><given-names>R.A.</given-names></name>
<name><surname>Ali</surname><given-names>I.</given-names></name>
</person-group><article-title>Health and environmental effects of persistent organic pollutants</article-title><source>J. Mol. Liq.</source><year>2018</year><volume>263</volume><fpage>442</fpage><lpage>453</lpage><pub-id pub-id-type="doi">10.1016/j.molliq.2018.05.029</pub-id></element-citation></ref><ref id="B10-toxics-13-00071"><label>10.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Dzierlenga</surname><given-names>M.</given-names></name>
<name><surname>Yoon</surname><given-names>M.</given-names></name>
<name><surname>Wania</surname><given-names>F.</given-names></name>
<name><surname>Ward</surname><given-names>P.</given-names></name>
<name><surname>Armitage</surname><given-names>J.</given-names></name>
<name><surname>Wood</surname><given-names>S.</given-names></name>
<name><surname>Clewell</surname><given-names>H.</given-names></name>
<name><surname>Longnecker</surname><given-names>M.</given-names></name>
</person-group><article-title>Quantitative bias analysis of the association of type 2 diabetes mellitus with 2,2&#x02032;,4,4&#x02032;,5,5&#x02032;-hexachlorobiphenyl (PCB-153)</article-title><source>Environ. Int.</source><year>2019</year><volume>125</volume><fpage>291</fpage><lpage>299</lpage><pub-id pub-id-type="doi">10.1016/j.envint.2018.12.036</pub-id><pub-id pub-id-type="pmid">30735960</pub-id>
</element-citation></ref><ref id="B11-toxics-13-00071"><label>11.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Yang</surname><given-names>B.</given-names></name>
<name><surname>Qin</surname><given-names>Q.</given-names></name>
<name><surname>Xu</surname><given-names>L.</given-names></name>
<name><surname>Lv</surname><given-names>X.</given-names></name>
<name><surname>Liu</surname><given-names>Z.</given-names></name>
<name><surname>Song</surname><given-names>E.</given-names></name>
<name><surname>Song</surname><given-names>Y.</given-names></name>
</person-group><article-title>Polychlorinated Biphenyl Quinone Promotes Atherosclerosis through Lipid Accumulation and Endoplasmic Reticulum Stress via CD36</article-title><source>Chem. Res. Toxicol.</source><year>2020</year><volume>33</volume><fpage>1497</fpage><lpage>1507</lpage><pub-id pub-id-type="doi">10.1021/acs.chemrestox.0c00123</pub-id><pub-id pub-id-type="pmid">32434321</pub-id>
</element-citation></ref><ref id="B12-toxics-13-00071"><label>12.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Gao</surname><given-names>X.</given-names></name>
<name><surname>Yan</surname><given-names>D.</given-names></name>
<name><surname>Li</surname><given-names>G.</given-names></name>
<name><surname>Wei</surname><given-names>Y.</given-names></name>
<name><surname>He</surname><given-names>H.</given-names></name>
<name><surname>Zhai</surname><given-names>J.</given-names></name>
</person-group><article-title>Polychlorinated biphenyls and risk of metabolic syndrome and comparison with the risk of diabetes: A systematic review and meta-analysis</article-title><source>Sci. Total Environ.</source><year>2023</year><volume>900</volume><fpage>165773</fpage><pub-id pub-id-type="doi">10.1016/j.scitotenv.2023.165773</pub-id><pub-id pub-id-type="pmid">37506918</pub-id>
</element-citation></ref><ref id="B13-toxics-13-00071"><label>13.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Raffetti</surname><given-names>E.</given-names></name>
<name><surname>Donat-Vargas</surname><given-names>C.</given-names></name>
<name><surname>Mentasti</surname><given-names>S.</given-names></name>
<name><surname>Chinotti</surname><given-names>A.</given-names></name>
<name><surname>Donato</surname><given-names>F.</given-names></name>
</person-group><article-title>Association between exposure to polychlorinated biphenyls and risk of hypertension: A systematic review and meta-analysis</article-title><source>Chemosphere</source><year>2020</year><volume>255</volume><fpage>126984</fpage><pub-id pub-id-type="doi">10.1016/j.chemosphere.2020.126984</pub-id><pub-id pub-id-type="pmid">32679627</pub-id>
</element-citation></ref><ref id="B14-toxics-13-00071"><label>14.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Bergkvist</surname><given-names>C.</given-names></name>
<name><surname>Berglund</surname><given-names>M.</given-names></name>
<name><surname>Glynn</surname><given-names>A.</given-names></name>
<name><surname>Julin</surname><given-names>B.</given-names></name>
<name><surname>Wolk</surname><given-names>A.</given-names></name>
<name><surname>&#x000c5;kesson</surname><given-names>A.</given-names></name>
</person-group><article-title>Dietary exposure to polychlorinated biphenyls and risk of myocardial infarction in men&#x02014;A population-based prospective cohort study</article-title><source>Environ. Int.</source><year>2016</year><volume>88</volume><fpage>9</fpage><lpage>14</lpage><pub-id pub-id-type="doi">10.1016/j.envint.2015.11.020</pub-id><pub-id pub-id-type="pmid">26690540</pub-id>
</element-citation></ref><ref id="B15-toxics-13-00071"><label>15.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Donat-Vargas</surname><given-names>C.</given-names></name>
<name><surname>Moreno-Franco</surname><given-names>B.</given-names></name>
<name><surname>Laclaustra</surname><given-names>M.</given-names></name>
<name><surname>Sandoval-Insausti</surname><given-names>H.</given-names></name>
<name><surname>Jarauta</surname><given-names>E.</given-names></name>
<name><surname>Guallar-Castillon</surname><given-names>P.</given-names></name>
</person-group><article-title>Exposure to dietary polychlorinated biphenyls and dioxins, and its relationship with subclinical coronary atherosclerosis: The Aragon Workers&#x02019; Health Study</article-title><source>Environ. Int.</source><year>2020</year><volume>136</volume><fpage>105433</fpage><pub-id pub-id-type="doi">10.1016/j.envint.2019.105433</pub-id><pub-id pub-id-type="pmid">31918334</pub-id>
</element-citation></ref><ref id="B16-toxics-13-00071"><label>16.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>P&#x000e9;rez-Carrascosa</surname><given-names>F.M.</given-names></name>
<name><surname>G&#x000f3;mez-Pe&#x000f1;a</surname><given-names>C.</given-names></name>
<name><surname>Echeverr&#x000ed;a</surname><given-names>R.</given-names></name>
<name><surname>Mole&#x000f3;n</surname><given-names>J.J.J.</given-names></name>
<name><surname>Melchor</surname><given-names>J.M.</given-names></name>
<name><surname>Garc&#x000ed;a-Ruiz</surname><given-names>A.</given-names></name>
<name><surname>Navarro-Espigares</surname><given-names>J.L.</given-names></name>
<name><surname>Cabeza-Barrera</surname><given-names>J.</given-names></name>
<name><surname>Martin-Olmedo</surname><given-names>P.</given-names></name>
<name><surname>Ortigosa-Garc&#x000ed;a</surname><given-names>J.C.</given-names></name>
<etal/>
</person-group><article-title>Historical exposure to persistent organic pollutants and cardiovascular disease: A 15-year longitudinal analysis focused on pharmaceutical consumption in primary care</article-title><source>Environ. Int.</source><year>2021</year><volume>156</volume><fpage>106734</fpage><pub-id pub-id-type="doi">10.1016/j.envint.2021.106734</pub-id><pub-id pub-id-type="pmid">34224998</pub-id>
</element-citation></ref><ref id="B17-toxics-13-00071"><label>17.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Deen</surname><given-names>L.</given-names></name>
<name><surname>Clark</surname><given-names>A.</given-names></name>
<name><surname>Hougaard</surname><given-names>K.S.</given-names></name>
<name><surname>Meyer</surname><given-names>H.W.</given-names></name>
<name><surname>Frederiksen</surname><given-names>M.</given-names></name>
<name><surname>Pedersen</surname><given-names>E.B.</given-names></name>
<name><surname>Petersen</surname><given-names>K.U.</given-names></name>
<name><surname>Flachs</surname><given-names>E.M.</given-names></name>
<name><surname>Bonde</surname><given-names>J.P.E.</given-names></name>
<name><surname>T&#x000f8;ttenborg</surname><given-names>S.S.</given-names></name>
</person-group><article-title>Risk of cardiovascular diseases following residential exposure to airborne polychlorinated biphenyls: A register-based cohort study</article-title><source>Environ. Res.</source><year>2023</year><volume>222</volume><fpage>115354</fpage><pub-id pub-id-type="doi">10.1016/j.envres.2023.115354</pub-id><pub-id pub-id-type="pmid">36709868</pub-id>
</element-citation></ref><ref id="B18-toxics-13-00071"><label>18.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Page</surname><given-names>M.J.</given-names></name>
<name><surname>McKenzie</surname><given-names>J.E.</given-names></name>
<name><surname>Bossuyt</surname><given-names>P.M.</given-names></name>
<name><surname>Boutron</surname><given-names>I.</given-names></name>
<name><surname>Hoffmann</surname><given-names>T.C.</given-names></name>
<name><surname>Mulrow</surname><given-names>C.D.</given-names></name>
<name><surname>Shamseer</surname><given-names>L.</given-names></name>
<name><surname>Tetzlaff</surname><given-names>J.M.</given-names></name>
<name><surname>Akl</surname><given-names>E.A.</given-names></name>
<name><surname>Brennan</surname><given-names>S.E.</given-names></name>
<etal/>
</person-group><article-title>The PRISMA 2020 statement: An updated guideline for reporting systematic reviews</article-title><source>J. Clin. Epidemiol.</source><year>2021</year><volume>134</volume><fpage>178</fpage><lpage>189</lpage><pub-id pub-id-type="doi">10.1016/j.jclinepi.2021.03.001</pub-id><pub-id pub-id-type="pmid">33789819</pub-id>
</element-citation></ref><ref id="B19-toxics-13-00071"><label>19.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Stroup</surname><given-names>D.F.</given-names></name>
<name><surname>Berlin</surname><given-names>J.A.</given-names></name>
<name><surname>Morton</surname><given-names>S.C.</given-names></name>
<name><surname>Olkin</surname><given-names>I.</given-names></name>
<name><surname>Williamson</surname><given-names>G.D.</given-names></name>
<name><surname>Rennie</surname><given-names>D.</given-names></name>
<name><surname>Moher</surname><given-names>D.</given-names></name>
<name><surname>Becker</surname><given-names>B.J.</given-names></name>
<name><surname>Sipe</surname><given-names>T.A.</given-names></name>
<name><surname>Thacker</surname><given-names>S.B.</given-names></name>
</person-group><article-title>Meta-analysis of observational studies in epidemiology: A proposal for reporting. Meta-analysis of Observational Studies in Epidemiology (MOOSE) group</article-title><source>JAMA</source><year>2000</year><volume>283</volume><fpage>2008</fpage><lpage>2012</lpage><pub-id pub-id-type="doi">10.1001/jama.283.15.2008</pub-id><pub-id pub-id-type="pmid">10789670</pub-id>
</element-citation></ref><ref id="B20-toxics-13-00071"><label>20.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Morgan</surname><given-names>R.L.</given-names></name>
<name><surname>Whaley</surname><given-names>P.</given-names></name>
<name><surname>Thayer</surname><given-names>K.A.</given-names></name>
<name><surname>Sch&#x000fc;nemann</surname><given-names>H.J.</given-names></name>
</person-group><article-title>Identifying the PECO: A framework for formulating good questions to explore the association of environmental and other exposures with health outcomes</article-title><source>Environ. Int.</source><year>2018</year><volume>121</volume><fpage>1027</fpage><lpage>1031</lpage><pub-id pub-id-type="doi">10.1016/j.envint.2018.07.015</pub-id><pub-id pub-id-type="pmid">30166065</pub-id>
</element-citation></ref><ref id="B21-toxics-13-00071"><label>21.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Masuda</surname><given-names>Y.</given-names></name>
</person-group><article-title>Toxic effects of PCB/PCDF to human observed in Yusho and other poisonings</article-title><source>Fukuoka Igaku Zasshi = Hukuoka Acta Medica</source><year>2009</year><volume>100</volume><fpage>141</fpage><lpage>155</lpage><pub-id pub-id-type="pmid">19588843</pub-id>
</element-citation></ref><ref id="B22-toxics-13-00071"><label>22.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Tang</surname><given-names>X.</given-names></name>
<name><surname>Tang</surname><given-names>S.</given-names></name>
<name><surname>Ren</surname><given-names>Z.</given-names></name>
<name><surname>Wong</surname><given-names>D.F.K.</given-names></name>
</person-group><article-title>Psychological risk and protective factors associated with depressive symptoms among adolescents in secondary schools in China: A systematic review and meta-analysis</article-title><source>Child. Youth Serv. Rev.</source><year>2020</year><volume>108</volume><fpage>104680</fpage><pub-id pub-id-type="doi">10.1016/j.childyouth.2019.104680</pub-id></element-citation></ref><ref id="B23-toxics-13-00071"><label>23.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Lee</surname><given-names>Y.H.</given-names></name>
</person-group><article-title>An overview of meta-analysis for clinicians</article-title><source>Korean J. Intern. Med.</source><year>2018</year><volume>33</volume><fpage>277</fpage><lpage>283</lpage><pub-id pub-id-type="doi">10.3904/kjim.2016.195</pub-id><pub-id pub-id-type="pmid">29277096</pub-id>
</element-citation></ref><ref id="B24-toxics-13-00071"><label>24.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Lee</surname><given-names>D.-H.</given-names></name>
<name><surname>Lind</surname><given-names>P.M.</given-names></name>
<name><surname>Jacobs</surname><given-names>D.R.</given-names></name>
<name><surname>Salihovic</surname><given-names>S.</given-names></name>
<name><surname>van Bavel</surname><given-names>B.</given-names></name>
<name><surname>Lind</surname><given-names>L.</given-names></name>
</person-group><article-title>Background exposure to persistent organic pollutants predicts stroke in the elderly</article-title><source>Environ. Int.</source><year>2012</year><volume>47</volume><fpage>115</fpage><lpage>120</lpage><pub-id pub-id-type="doi">10.1016/j.envint.2012.06.009</pub-id><pub-id pub-id-type="pmid">22809777</pub-id>
</element-citation></ref><ref id="B25-toxics-13-00071"><label>25.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Bergkvist</surname><given-names>C.</given-names></name>
<name><surname>Kippler</surname><given-names>M.</given-names></name>
<name><surname>Larsson</surname><given-names>S.C.</given-names></name>
<name><surname>Berglund</surname><given-names>M.</given-names></name>
<name><surname>Glynn</surname><given-names>A.</given-names></name>
<name><surname>Wolk</surname><given-names>A.</given-names></name>
<name><surname>&#x000c5;kesson</surname><given-names>A.</given-names></name>
</person-group><article-title>Dietary exposure to polychlorinated biphenyls is associated with increased risk of stroke in women</article-title><source>J. Intern. Med.</source><year>2014</year><volume>276</volume><fpage>248</fpage><lpage>259</lpage><pub-id pub-id-type="doi">10.1111/joim.12194</pub-id><pub-id pub-id-type="pmid">24428778</pub-id>
</element-citation></ref><ref id="B26-toxics-13-00071"><label>26.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Lim</surname><given-names>J.-E.</given-names></name>
<name><surname>Lee</surname><given-names>S.</given-names></name>
<name><surname>Lee</surname><given-names>S.</given-names></name>
<name><surname>Jee</surname><given-names>S.H.</given-names></name>
</person-group><article-title>Serum persistent organic pollutants levels and stroke risk</article-title><source>Environ. Pollut.</source><year>2018</year><volume>233</volume><fpage>855</fpage><lpage>861</lpage><pub-id pub-id-type="doi">10.1016/j.envpol.2017.12.031</pub-id><pub-id pub-id-type="pmid">29248762</pub-id>
</element-citation></ref><ref id="B27-toxics-13-00071"><label>27.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Raffetti</surname><given-names>E.</given-names></name>
<name><surname>Donato</surname><given-names>F.</given-names></name>
<name><surname>Speziani</surname><given-names>F.</given-names></name>
<name><surname>Scarcella</surname><given-names>C.</given-names></name>
<name><surname>Gaia</surname><given-names>A.</given-names></name>
<name><surname>Magoni</surname><given-names>M.</given-names></name>
</person-group><article-title>Polychlorinated biphenyls (PCBs) exposure and cardiovascular, endocrine and metabolic diseases: A population-based cohort study in a North Italian highly polluted area</article-title><source>Environ. Int.</source><year>2018</year><volume>120</volume><fpage>215</fpage><lpage>222</lpage><pub-id pub-id-type="doi">10.1016/j.envint.2018.08.022</pub-id><pub-id pub-id-type="pmid">30103120</pub-id>
</element-citation></ref><ref id="B28-toxics-13-00071"><label>28.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Li</surname><given-names>P.</given-names></name>
<name><surname>Dan</surname><given-names>Y.</given-names></name>
<name><surname>Li</surname><given-names>S.</given-names></name>
<name><surname>Zhang</surname><given-names>Q.</given-names></name>
<name><surname>Su</surname><given-names>Y.</given-names></name>
<name><surname>Lu</surname><given-names>M.</given-names></name>
</person-group><article-title>Serum levels of polychlorinated biphenyls and stroke risk among Chinese: A hospital-based case-control study</article-title><source>Acta Neurol. Belg.</source><year>2020</year><volume>121</volume><fpage>1217</fpage><lpage>1224</lpage><pub-id pub-id-type="doi">10.1007/s13760-020-01392-5</pub-id><pub-id pub-id-type="pmid">32535835</pub-id>
</element-citation></ref><ref id="B29-toxics-13-00071"><label>29.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Donat-Vargas</surname><given-names>C.</given-names></name>
<name><surname>Schillemans</surname><given-names>T.</given-names></name>
<name><surname>Kiviranta</surname><given-names>H.</given-names></name>
<name><surname>Rantakokko</surname><given-names>P.</given-names></name>
<name><surname>de Faire</surname><given-names>U.</given-names></name>
<name><surname>Arrebola</surname><given-names>J.P.</given-names></name>
<name><surname>Wolk</surname><given-names>A.</given-names></name>
<name><surname>Leander</surname><given-names>K.</given-names></name>
<name><surname>&#x000c5;kesson</surname><given-names>A.</given-names></name>
</person-group><article-title>Blood Levels of Organochlorine Contaminants Mixtures and Cardiovascular Disease</article-title><source>JAMA Netw. Open</source><year>2023</year><volume>6</volume><fpage>e2333347</fpage><pub-id pub-id-type="doi">10.1001/jamanetworkopen.2023.33347</pub-id><pub-id pub-id-type="pmid">37698859</pub-id>
</element-citation></ref><ref id="B30-toxics-13-00071"><label>30.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Schillemans</surname><given-names>T.</given-names></name>
<name><surname>Yan</surname><given-names>Y.</given-names></name>
<name><surname>Ribbenstedt</surname><given-names>A.</given-names></name>
<name><surname>Donat-Vargas</surname><given-names>C.</given-names></name>
<name><surname>Lindh</surname><given-names>C.H.</given-names></name>
<name><surname>Kiviranta</surname><given-names>H.</given-names></name>
<name><surname>Rantakokko</surname><given-names>P.</given-names></name>
<name><surname>Wolk</surname><given-names>A.</given-names></name>
<name><surname>Landberg</surname><given-names>R.</given-names></name>
<name><surname>&#x000c5;kesson</surname><given-names>A.</given-names></name>
<etal/>
</person-group><article-title>OMICs Signatures Linking Persistent Organic Pollutants to Cardiovascular Disease in the Swedish Mammography Cohort</article-title><source>Environ. Sci. Technol.</source><year>2024</year><volume>58</volume><fpage>1036</fpage><lpage>1047</lpage><pub-id pub-id-type="doi">10.1021/acs.est.3c06388</pub-id><pub-id pub-id-type="pmid">38174696</pub-id>
</element-citation></ref><ref id="B31-toxics-13-00071"><label>31.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Brouwer</surname><given-names>A.</given-names></name>
<name><surname>Longnecker</surname><given-names>M.P.</given-names></name>
<name><surname>Birnbaum</surname><given-names>L.S.</given-names></name>
<name><surname>Cogliano</surname><given-names>J.</given-names></name>
<name><surname>Kostyniak</surname><given-names>P.</given-names></name>
<name><surname>Moore</surname><given-names>J.</given-names></name>
<name><surname>Schantz</surname><given-names>S.</given-names></name>
<name><surname>Winneke</surname><given-names>G.</given-names></name>
</person-group><article-title>Characterization of potential endocrine-related health effects at low-dose levels of exposure to PCBs</article-title><source>Environ. Health Perspect.</source><year>1999</year><volume>107</volume><issue>(Suppl. S4)</issue><fpage>639</fpage><lpage>649</lpage><pub-id pub-id-type="doi">10.2307/3434557</pub-id><pub-id pub-id-type="pmid">10421775</pub-id>
</element-citation></ref><ref id="B32-toxics-13-00071"><label>32.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Ma</surname><given-names>R.</given-names></name>
<name><surname>Sassoon</surname><given-names>D.A.</given-names></name>
</person-group><article-title>PCBs exert an estrogenic effect through repression of the Wnt7a signaling pathway in the female reproductive tract</article-title><source>Environ. Health Perspect.</source><year>2006</year><volume>114</volume><fpage>898</fpage><lpage>904</lpage><pub-id pub-id-type="doi">10.1289/ehp.8748</pub-id><pub-id pub-id-type="pmid">16759992</pub-id>
</element-citation></ref><ref id="B33-toxics-13-00071"><label>33.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Murphy</surname><given-names>M.O.</given-names></name>
<name><surname>Petriello</surname><given-names>M.C.</given-names></name>
<name><surname>Han</surname><given-names>S.G.</given-names></name>
<name><surname>Sunkara</surname><given-names>M.</given-names></name>
<name><surname>Morris</surname><given-names>A.J.</given-names></name>
<name><surname>Esser</surname><given-names>K.</given-names></name>
<name><surname>Hennig</surname><given-names>B.</given-names></name>
</person-group><article-title>Exercise protects against PCB-induced inflammation and associated cardiovascular risk factors</article-title><source>Environ. Sci. Pollut. Res.</source><year>2015</year><volume>23</volume><fpage>2201</fpage><lpage>2211</lpage><pub-id pub-id-type="doi">10.1007/s11356-014-4062-6</pub-id><pub-id pub-id-type="pmid">25586614</pub-id>
</element-citation></ref><ref id="B34-toxics-13-00071"><label>34.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Jabbar</surname><given-names>A.</given-names></name>
<name><surname>Pingitore</surname><given-names>A.</given-names></name>
<name><surname>Pearce</surname><given-names>S.H.S.</given-names></name>
<name><surname>Zaman</surname><given-names>A.</given-names></name>
<name><surname>Iervasi</surname><given-names>G.</given-names></name>
<name><surname>Razvi</surname><given-names>S.</given-names></name>
</person-group><article-title>Thyroid hormones and cardiovascular disease</article-title><source>Nat. Rev. Cardiol.</source><year>2016</year><volume>14</volume><fpage>39</fpage><lpage>55</lpage><pub-id pub-id-type="doi">10.1038/nrcardio.2016.174</pub-id><pub-id pub-id-type="pmid">27811932</pub-id>
</element-citation></ref><ref id="B35-toxics-13-00071"><label>35.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>El Amine</surname><given-names>Z.</given-names></name>
<name><surname>Mauger</surname><given-names>J.-F.</given-names></name>
<name><surname>Imbeault</surname><given-names>P.</given-names></name>
</person-group><article-title>CYP1A1, VEGFA and Adipokine Responses of Human Adipocytes Co-Exposed to PCB126 and Hypoxia</article-title><source>Cells</source><year>2022</year><volume>11</volume><elocation-id>2282</elocation-id><pub-id pub-id-type="doi">10.3390/cells11152282</pub-id><pub-id pub-id-type="pmid">35892579</pub-id>
</element-citation></ref><ref id="B36-toxics-13-00071"><label>36.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Long</surname><given-names>Y.</given-names></name>
<name><surname>Liu</surname><given-names>X.</given-names></name>
<name><surname>Tan</surname><given-names>X.-Z.</given-names></name>
<name><surname>Jiang</surname><given-names>C.-X.</given-names></name>
<name><surname>Chen</surname><given-names>S.-W.</given-names></name>
<name><surname>Liang</surname><given-names>G.-N.</given-names></name>
<name><surname>He</surname><given-names>X.-M.</given-names></name>
<name><surname>Wu</surname><given-names>J.</given-names></name>
<name><surname>Chen</surname><given-names>T.</given-names></name>
<name><surname>Xu</surname><given-names>Y.</given-names></name>
</person-group><article-title>ROS-induced NLRP3 inflammasome priming and activation mediate PCB 118-induced pyroptosis in endothelial cells</article-title><source>Ecotox. Environ. Saf.</source><year>2020</year><volume>189</volume><fpage>109937</fpage><pub-id pub-id-type="doi">10.1016/j.ecoenv.2019.109937</pub-id></element-citation></ref><ref id="B37-toxics-13-00071"><label>37.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Mesnier</surname><given-names>A.</given-names></name>
<name><surname>Champion</surname><given-names>S.</given-names></name>
<name><surname>Louis</surname><given-names>L.</given-names></name>
<name><surname>Sauzet</surname><given-names>C.</given-names></name>
<name><surname>May</surname><given-names>P.</given-names></name>
<name><surname>Portugal</surname><given-names>H.</given-names></name>
<name><surname>Benbrahim</surname><given-names>K.</given-names></name>
<name><surname>Abraldes</surname><given-names>J.</given-names></name>
<name><surname>Alessi</surname><given-names>M.-C.</given-names></name>
<name><surname>Amiot-Carlin</surname><given-names>M.-J.</given-names></name>
<etal/>
</person-group><article-title>The Transcriptional Effects of PCB118 and PCB153 on the Liver, Adipose Tissue, Muscle and Colon of Mice: Highlighting of Glut4 and Lipin1 as Main Target Genes for PCB Induced Metabolic Disorders</article-title><source>PLoS ONE</source><year>2015</year><volume>10</volume><elocation-id>e0128847</elocation-id><pub-id pub-id-type="doi">10.1371/journal.pone.0128847</pub-id><pub-id pub-id-type="pmid">26086818</pub-id>
</element-citation></ref><ref id="B38-toxics-13-00071"><label>38.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Li</surname><given-names>Z.</given-names></name>
<name><surname>Sandau</surname><given-names>C.D.</given-names></name>
<name><surname>Romanoff</surname><given-names>L.C.</given-names></name>
<name><surname>Caudill</surname><given-names>S.P.</given-names></name>
<name><surname>Sjodin</surname><given-names>A.</given-names></name>
<name><surname>Needham</surname><given-names>L.L.</given-names></name>
<name><surname>Patterson</surname><given-names>D.G.</given-names></name>
</person-group><article-title>Concentration and profile of 22 urinary polycyclic aromatic hydrocarbon metabolites in the US population</article-title><source>Environ. Res.</source><year>2008</year><volume>107</volume><fpage>320</fpage><lpage>331</lpage><pub-id pub-id-type="doi">10.1016/j.envres.2008.01.013</pub-id><pub-id pub-id-type="pmid">18313659</pub-id>
</element-citation></ref><ref id="B39-toxics-13-00071"><label>39.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Hansen</surname><given-names>L.G.</given-names></name>
</person-group><article-title>Stepping backward to improve assessment of PCB congener toxicities</article-title><source>Environ. Health Perspect.</source><year>1998</year><volume>106</volume><issue>(Suppl. S1)</issue><fpage>171</fpage><lpage>189</lpage><pub-id pub-id-type="doi">10.2307/3433919</pub-id><pub-id pub-id-type="pmid">9539012</pub-id>
</element-citation></ref><ref id="B40-toxics-13-00071"><label>40.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Patterson</surname><given-names>D.G.</given-names></name>
<name><surname>Todd</surname><given-names>G.D.</given-names></name>
<name><surname>E Turner</surname><given-names>W.</given-names></name>
<name><surname>Maggio</surname><given-names>V.</given-names></name>
<name><surname>Alexander</surname><given-names>L.R.</given-names></name>
<name><surname>Needham</surname><given-names>L.L.</given-names></name>
</person-group><article-title>Levels of non-ortho-substituted (coplanar), mono- and di-ortho-substituted polychlorinated biphenyls, dibenzo-p-dioxins, and dibenzofurans in human serum and adipose tissue</article-title><source>Environ. Health Perspect.</source><year>1994</year><volume>102</volume><issue>(Suppl. S1)</issue><fpage>195</fpage><lpage>204</lpage><pub-id pub-id-type="doi">10.1289/ehp.94102s1195</pub-id></element-citation></ref></ref-list></back><floats-group><fig position="float" id="toxics-13-00071-f001"><label>Figure 1</label><caption><p>A literature screening flow chart identified a total of 11 articles.</p></caption><graphic xlink:href="toxics-13-00071-g001" position="float"/></fig><fig position="float" id="toxics-13-00071-f002"><label>Figure 2</label><caption><p>Forest plot of overall analysis of PCBs and CVDs [<xref rid="B14-toxics-13-00071" ref-type="bibr">14</xref>,<xref rid="B15-toxics-13-00071" ref-type="bibr">15</xref>,<xref rid="B16-toxics-13-00071" ref-type="bibr">16</xref>,<xref rid="B17-toxics-13-00071" ref-type="bibr">17</xref>,<xref rid="B24-toxics-13-00071" ref-type="bibr">24</xref>,<xref rid="B25-toxics-13-00071" ref-type="bibr">25</xref>,<xref rid="B26-toxics-13-00071" ref-type="bibr">26</xref>,<xref rid="B27-toxics-13-00071" ref-type="bibr">27</xref>,<xref rid="B28-toxics-13-00071" ref-type="bibr">28</xref>,<xref rid="B29-toxics-13-00071" ref-type="bibr">29</xref>,<xref rid="B30-toxics-13-00071" ref-type="bibr">30</xref>].</p></caption><graphic xlink:href="toxics-13-00071-g002" position="float"/></fig><fig position="float" id="toxics-13-00071-f003"><label>Figure 3</label><caption><p>Funnel plot of total PCBs and CVDs overall analysis.</p></caption><graphic xlink:href="toxics-13-00071-g003" position="float"/></fig><fig position="float" id="toxics-13-00071-f004"><label>Figure 4</label><caption><p>Graph of sensitivity analysis results for the overall analysis of total PCBs and CVDs [<xref rid="B14-toxics-13-00071" ref-type="bibr">14</xref>,<xref rid="B15-toxics-13-00071" ref-type="bibr">15</xref>,<xref rid="B16-toxics-13-00071" ref-type="bibr">16</xref>,<xref rid="B17-toxics-13-00071" ref-type="bibr">17</xref>,<xref rid="B24-toxics-13-00071" ref-type="bibr">24</xref>,<xref rid="B25-toxics-13-00071" ref-type="bibr">25</xref>,<xref rid="B26-toxics-13-00071" ref-type="bibr">26</xref>,<xref rid="B27-toxics-13-00071" ref-type="bibr">27</xref>,<xref rid="B28-toxics-13-00071" ref-type="bibr">28</xref>,<xref rid="B29-toxics-13-00071" ref-type="bibr">29</xref>,<xref rid="B30-toxics-13-00071" ref-type="bibr">30</xref>].</p></caption><graphic xlink:href="toxics-13-00071-g004" position="float"/></fig><fig position="float" id="toxics-13-00071-f005"><label>Figure 5</label><caption><p>Newcastle&#x02013;Ottawa Scale (NOS)&#x02014;Quality assessment. The quality of the studies was evaluated using the NOS. D1&#x02013;D8 represent NOS items for case-control and cohort studies, while D1&#x02013;D7 represent adapted NOS items for cross-sectional studies. + for low risk, &#x02212; for high risk, ? Unclear representation [<xref rid="B14-toxics-13-00071" ref-type="bibr">14</xref>,<xref rid="B15-toxics-13-00071" ref-type="bibr">15</xref>,<xref rid="B16-toxics-13-00071" ref-type="bibr">16</xref>,<xref rid="B17-toxics-13-00071" ref-type="bibr">17</xref>,<xref rid="B24-toxics-13-00071" ref-type="bibr">24</xref>,<xref rid="B25-toxics-13-00071" ref-type="bibr">25</xref>,<xref rid="B26-toxics-13-00071" ref-type="bibr">26</xref>,<xref rid="B27-toxics-13-00071" ref-type="bibr">27</xref>,<xref rid="B28-toxics-13-00071" ref-type="bibr">28</xref>,<xref rid="B29-toxics-13-00071" ref-type="bibr">29</xref>,<xref rid="B30-toxics-13-00071" ref-type="bibr">30</xref>].</p></caption><graphic xlink:href="toxics-13-00071-g005" position="float"/></fig><fig position="float" id="toxics-13-00071-f006"><label>Figure 6</label><caption><p>Forest plots with literature quality as subgroup [<xref rid="B14-toxics-13-00071" ref-type="bibr">14</xref>,<xref rid="B15-toxics-13-00071" ref-type="bibr">15</xref>,<xref rid="B16-toxics-13-00071" ref-type="bibr">16</xref>,<xref rid="B17-toxics-13-00071" ref-type="bibr">17</xref>,<xref rid="B24-toxics-13-00071" ref-type="bibr">24</xref>,<xref rid="B25-toxics-13-00071" ref-type="bibr">25</xref>,<xref rid="B26-toxics-13-00071" ref-type="bibr">26</xref>,<xref rid="B27-toxics-13-00071" ref-type="bibr">27</xref>,<xref rid="B28-toxics-13-00071" ref-type="bibr">28</xref>,<xref rid="B29-toxics-13-00071" ref-type="bibr">29</xref>,<xref rid="B30-toxics-13-00071" ref-type="bibr">30</xref>].</p></caption><graphic xlink:href="toxics-13-00071-g006" position="float"/></fig><fig position="float" id="toxics-13-00071-f007"><label>Figure 7</label><caption><p>Forest plots of PCBs and CVDs with biomaterial as a subgroup [<xref rid="B14-toxics-13-00071" ref-type="bibr">14</xref>,<xref rid="B15-toxics-13-00071" ref-type="bibr">15</xref>,<xref rid="B17-toxics-13-00071" ref-type="bibr">17</xref>,<xref rid="B24-toxics-13-00071" ref-type="bibr">24</xref>,<xref rid="B25-toxics-13-00071" ref-type="bibr">25</xref>,<xref rid="B26-toxics-13-00071" ref-type="bibr">26</xref>,<xref rid="B27-toxics-13-00071" ref-type="bibr">27</xref>,<xref rid="B28-toxics-13-00071" ref-type="bibr">28</xref>,<xref rid="B30-toxics-13-00071" ref-type="bibr">30</xref>].</p></caption><graphic xlink:href="toxics-13-00071-g007" position="float"/></fig><fig position="float" id="toxics-13-00071-f008"><label>Figure 8</label><caption><p>Forest map with research method as subgroup [<xref rid="B14-toxics-13-00071" ref-type="bibr">14</xref>,<xref rid="B16-toxics-13-00071" ref-type="bibr">16</xref>,<xref rid="B17-toxics-13-00071" ref-type="bibr">17</xref>,<xref rid="B24-toxics-13-00071" ref-type="bibr">24</xref>,<xref rid="B25-toxics-13-00071" ref-type="bibr">25</xref>,<xref rid="B26-toxics-13-00071" ref-type="bibr">26</xref>,<xref rid="B27-toxics-13-00071" ref-type="bibr">27</xref>,<xref rid="B28-toxics-13-00071" ref-type="bibr">28</xref>,<xref rid="B29-toxics-13-00071" ref-type="bibr">29</xref>,<xref rid="B30-toxics-13-00071" ref-type="bibr">30</xref>].</p></caption><graphic xlink:href="toxics-13-00071-g008" position="float"/></fig><fig position="float" id="toxics-13-00071-f009"><label>Figure 9</label><caption><p>Forest map with PCB types as subgroup [<xref rid="B24-toxics-13-00071" ref-type="bibr">24</xref>,<xref rid="B26-toxics-13-00071" ref-type="bibr">26</xref>,<xref rid="B27-toxics-13-00071" ref-type="bibr">27</xref>,<xref rid="B28-toxics-13-00071" ref-type="bibr">28</xref>,<xref rid="B29-toxics-13-00071" ref-type="bibr">29</xref>].</p></caption><graphic xlink:href="toxics-13-00071-g009" position="float"/></fig><table-wrap position="float" id="toxics-13-00071-t001"><object-id pub-id-type="pii">toxics-13-00071-t001_Table 1</object-id><label>Table 1</label><caption><p>Main features of the included literature.</p></caption><table frame="hsides" rules="groups"><thead><tr><th align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1">Reference</th><th align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1">Location</th><th align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1">Study Design</th><th align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1">Study<break/>Population</th><th align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1">Time-<break/>Period</th><th align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1">Sample Size</th><th align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1">Age<break/>(Year)</th><th align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1">Ratio of<break/>Sex</th><th align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1">Biomaterials</th><th align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1">PCBs Type</th><th align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1">Method of<break/>Measurement</th><th align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1">Results <sup>a</sup></th><th align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1">Main Finding</th></tr></thead><tbody><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Charlotte Bergkvist et al. (2016) [<xref rid="B14-toxics-13-00071" ref-type="bibr">14</xref>]</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Swedish</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Cohort study</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Lived in Central Sweden and did not have cardiovascular disease.</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">1998&#x02013;2009</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">36,759</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">45&#x02013;79</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">All male</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Serum</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">6 PCB congeners</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Unclear</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">&#x003a3;PCBs OR 1.97 95% CI [1.42&#x02013;2.75)] <sup>b</sup></td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Exposure to PCBs via diet was associated with increased risk of myocardial infarction in men.</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Carolina Donat-Vargas et al. (2020) [<xref rid="B15-toxics-13-00071" ref-type="bibr">15</xref>]</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Aragon</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Cross-sectional</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Men without cardiovascular disease enrolled in the Aragon Workers&#x02019; Health Study</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">2011&#x02013;2014</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">1844</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">40&#x02013;60</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">All male</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Serum</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">4 PCB<break/>Congeners</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Computerized tomography</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">&#x003a3;PCBs<break/>OR 2.03,<break/>95% CI [1.21&#x02013;3.40]</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">PCB exposure<break/>seems to increase the risk of coronary disease in men from the very early stages.</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Francisco Miguel P&#x000b4;erez-Carrascosa et al. (2021) [<xref rid="B16-toxics-13-00071" ref-type="bibr">16</xref>]</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Spanish</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Cohort study</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Participants were recruited in two hospitals in<break/>Granada province, Southern Spain.</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">15-year<break/>follow-up<break/>study</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">387</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Unclear</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Unclear</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Adipose tissue</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">3 PCB congeners</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Gas chromatography coupled to mass<break/>spectrometry in tandem mode</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Main PCB138 OR 1.75, 95% CI [1.18&#x02013;2.60]</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Long-term PCB exposure might represent a modifiable risk factor for CVD.</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Laura Deen et al. (2023) [<xref rid="B17-toxics-13-00071" ref-type="bibr">17</xref>]</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Danish</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Cohort study</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">The HESPAIR cohort includes all residents of two residential areas in<break/>the Greater Copenhagen area</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">21-year<break/>follow-up<break/>study</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">51,249</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Children and adults</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Unclear</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Plasma</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">7 PCB congeners</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Unclear</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">&#x003a3;PCBs HR 1.02, 95% CI [0.94&#x02013;1.10]</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Cumulative residential exposure to airborne PCB was not associated with a higher overall risk for CVD.</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Duk-Hee Lee et al. (2012) [<xref rid="B24-toxics-13-00071" ref-type="bibr">24</xref>]</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Swedish</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Cohort study</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Study subjects at baseline were 1016 subjects who were 70 years<break/>old and residents of Uppsala</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">5-year<break/>follow-up<break/>study</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">898</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">70</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Unclear</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Plasma</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">16 PCB congeners</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">HRGC/HRMS</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">&#x003a3;PCBs OR 5.5 95% CI [1.7&#x02013;18.1]</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Background exposure to POPs may play an important role in development or progression of<break/>stroke in the elderly.</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Charlotte Bergkvist et al. (2014) [<xref rid="B25-toxics-13-00071" ref-type="bibr">25</xref>]</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Swedish</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Cohort study</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Women residing in central Sweden</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">12-year<break/>follow-up<break/>study</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">34,591</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Unclear</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">All<break/>women</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Serum</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">6 PCBs</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Unclear</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">&#x003a3;PCBs<break/>OR 1.65; 95% CI [1.27&#x02013;2.15]</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Dietary exposure to PCBs was associated with an increased stroke risk in women, especially haemorrhagic stroke.</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Jung-eun Lim et al. (2018) [<xref rid="B26-toxics-13-00071" ref-type="bibr">26</xref>]</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Korean</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Case-control study</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Participants in routine health assessment at 11 health promotion centers in Seoul and Gyeonggi Province</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">2004&#x02013;2013</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">637</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">&#x0003e;20</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Unclear</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Serum</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">32 PCBs</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">GC/HRMS</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">&#x003a3;PCBs<break/>OR 1.66; 95% CI [0.8&#x02013;3.45] &#x003a3;DL-PCBs OR: 3.17; 95% CI [1.29&#x02013;7.77] &#x003a3;NDL-PCBs OR: 1.76; 95% CI [0.88&#x02013;3.5]</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Elevated serum POPs levels were associated with an increased risk of stroke, especially ischemic stroke.</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Elena Raffetti et al. (2018) [<xref rid="B27-toxics-13-00071" ref-type="bibr">27</xref>]</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">North Italy</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Cohort study</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Urban residents near chemical plants that produce PCBs</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">2001&#x02013;2013</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">1331</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Mean age 50.6 years</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">45.7% males and 54.3% women</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Serum</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">24 PCBs</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Hewlett&#x02013;Packard<break/>6890 N gas chromatograph coupled with an MSD HP 5973.</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">&#x003a3;PCBs RR 2.07, 95% CI [1.18&#x02013;3.63]</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">These results suggest that PCBs might play a role in the development of possibly<break/>cardiovascular disease, though alternative explanations are to be considered, too.</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">PingLi et al. (2020) [<xref rid="B28-toxics-13-00071" ref-type="bibr">28</xref>]</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">China</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Case-control study</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Stroke Patients and Healthy Population Recruited at Tianjin Hospital, China</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">2017&#x02013;2019</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">482</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">&#x0003e;20</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">56% males and 44% women</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Serum</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">17 PCBs</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">GC/MS</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">&#x003a3;PCBs<break/>OR 1.704; 95% CI [1.073&#x02013;2.506]<break/>&#x003a3;DL-PCBs OR: 1.846; 95% CI [1.156&#x02013;2.949]</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">The results suggest detrimental roles of PCBs, mainly dioxin-like PCBs, in stroke risk, irrespective of stroke subtypes.</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Carolina Donat-Vargas et al. (2023) [<xref rid="B29-toxics-13-00071" ref-type="bibr">29</xref>]</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Swedish</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Cohort study</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">The SMC included women born from<break/>1914 to 1948 residing in central Sweden</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Mean age 61: 15-year<break/>follow-up<break/>study<break/>Mean age</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">1528</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Mean age 61</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">33% males and 67% women</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Blood lipids</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">12 PCBs</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Gas<break/>chromatography&#x02013;triple quadrupole mass spectrometry</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">&#x003a3;PCBs OR 1.28; 95% CI, [0.92&#x02013;1.79]</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Dioxin-like PCBs<break/>and non-dioxin-<break/>like PCBs were<break/>significantly<break/>associated with<break/>cardiovascular disease.</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Tessa Schillemans et al. (2024) [<xref rid="B30-toxics-13-00071" ref-type="bibr">30</xref>]</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Swedish</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Nested case-control design</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">The study used data from the<break/>SMC-C, which is part of the Swedish Infrastructure for<break/>Medical Population-Based Life-Course and Environmental<break/>Research</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">2003&#x02013;2009</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">657</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">&#x0003c;85</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">All Women</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Plasma</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">13 PCB congeners</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">GC-MS/MS</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">&#x003a3;PCBs OR 1.55; 95% CI [1.16&#x02013;2.09]</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">PCBs correlated positively with omics associated with increased MI and stroke risk.</td></tr></tbody></table><table-wrap-foot><fn><p><sup>a</sup> The estimation is presented for the highest category compared with the lowest for the most adjusted model. <sup>b</sup> Estimated full intake.</p></fn></table-wrap-foot></table-wrap></floats-group></article>